TransCode Therapeutics (RNAZ) Announces 1:28 Reverse Share Split

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to TransCode Therapeutics (RNAZ) Announces 1:28 Reverse Share Split

TransCode Therapeutics Announces 1-for-28 Reverse Stock Split

May 2, 2025 4:10 PM EDT

Split designed to achieve compliance with Nasdaq minimum bid price requirements

BOSTON, May 2, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), the RNA Oncology Company committed to more effectively treating cancer using RNA therapeutics, today announced that its Board of Directors has approved a 1-for-28 reverse stock split. The reverse stock split was approved by TransCode's stockholders on May 2, 2025, and is intended to increase the per... More